Rainbow BioSciences, LLC: Scientific Reports Introduces the World to n3D's New Biotech Apple (AAPL) iPhone App
10/21/2013 9:59:37 AM
NOKOMIS, Fla.--(BUSINESS WIRE)--Joint venture partners Rainbow Coral Corp. (OTCBB: RBCC) and Nano3D Biosciences (n3D) are proud to announce that the journal Scientific Reports published the first research document detailing the efficacy of n3D’s revolutionary new Apple (NASDAQ: AAPL) iPhone app today. RBCC and n3D have joined forces to develop and market the BiO Assay, a new automated toxicity assay system that harnesses the multi-function computing power of Apple mobile devices to test a drug’s effects by capturing and charting cell migration data. The Experiment Assistant app, when used with n3D’s n3Dock Station and 3D cell culturing technology, organizes and takes time-lapse images of 3D cell culture growth and migration in the presence of a drug.
Help employers find you! Check out all the jobs and post your resume.